CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 82 filers reported holding CULLINAN ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $76,056 | -23.5% | 8,404 | -9.0% | 0.05% | -22.0% |
| Q2 2023 | $99,412 | +14.6% | 9,239 | +8.9% | 0.06% | +22.9% |
| Q1 2023 | $86,781 | -30.0% | 8,483 | -27.8% | 0.05% | -26.2% |
| Q4 2022 | $123,973 | +11.7% | 11,751 | +35.3% | 0.06% | +47.7% |
| Q3 2022 | $111,000 | 0.0% | 8,686 | +0.8% | 0.04% | +7.3% |
| Q2 2022 | $111,000 | +6.7% | 8,620 | -13.3% | 0.04% | -12.8% |
| Q1 2022 | $104,000 | -36.2% | 9,941 | -5.6% | 0.05% | -24.2% |
| Q4 2021 | $163,000 | +4.5% | 10,536 | +52.1% | 0.06% | -10.1% |
| Q3 2021 | $156,000 | -16.6% | 6,925 | -4.9% | 0.07% | -10.4% |
| Q2 2021 | $187,000 | – | 7,281 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 7,648,268 | $118,013,000 | 21.52% |
| CHI Advisors LLC | 2,476,720 | $38,215,000 | 12.68% |
| Nextech Invest Ltd. | 1,221,145 | $18,842,000 | 4.96% |
| Foresite Capital Management V, LLC | 1,143,006 | $17,637,000 | 4.33% |
| Foresite Capital Opportunity Management V, LLC | 381,002 | $5,879,000 | 3.94% |
| BVF INC/IL | 5,369,459 | $82,851,000 | 3.01% |
| Boxer Capital, LLC | 1,074,082 | $16,573,000 | 0.64% |
| Logos Global Management LP | 288,458 | $4,450,000 | 0.46% |
| Birchview Capital, LP | 45,114 | $696,000 | 0.45% |
| Eventide Asset Management | 1,440,145 | $21,665,000 | 0.28% |